Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan
Clinical trial NCT06199973 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06199973
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-04-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.